• DRAMP ID

    • DRAMP31559
    • Peptide Name

    • SARS-CoV S (192-203), SP-4
    • Source

    • Synthetic construct
    • Family

    • Coronaviridae
    • Gene

    • Not found
    • Sequence

    • GFLYVYKGYQPI
    • Sequence Length

    • 12
    • Protein Existence

    • Not found
    • Biological Activity

    • Antimicrobial, Antiviral
    • Target Organism

      • [Ref.16337697]SARS-CoV: Inhibition of pseudovirus infection in Vero cells(IC50=4.30 ± 2.18 nM).
    • Hemolytic Activity

      • No hemolysis information or data found in the reference(s) presented in this entry
    • Cytotoxicity

      • No cytotoxicity information or data found in the reference(s) presented in this entry
    • Binding Target

    • ACE2
    • Linear/Cyclic

    • Linear
    • N-terminal Modification

    • Free
    • C-terminal Modification

    • Free
    • Nonterminal Modifications and Unusual Amino Acids

    • None
    • Stereochemistry

    • L
    • Structure

    • Not found
    • Structure Description

    • Not found
    • Helical Wheel Diagram

    • DRAMP31559 helical wheel diagram
    • PDB ID

    • None
    • Predicted Structure

    • There is no predicted structure for DRAMP31559.
    • Formula

    • C73H102N14O17
    • Absent Amino Acids

    • ACDEHMNRSTW
    • Common Amino Acids

    • Y
    • Mass

    • 1447.7
    • PI

    • 8.43
    • Basic Residues

    • 1
    • Acidic Residues

    • 0
    • Hydrophobic Residues

    • 4
    • Net Charge

    • +1
    • Boman Index

    • 723
    • Hydrophobicity

    • 0.133
    • Aliphatic Index

    • 89.17
    • Half Life

      • Mammalian:30 hour
      • Yeast:>20 hour
      • E.coli:>10 hour
    • Extinction Coefficient Cystines

    • 4470
    • Absorbance 280nm

    • 406.36
    • Polar Residues

    • 5

DRAMP31559

    • Mechanism

    • block the binding of S protein to ACE2.
  • ·Literature 1
    • Title

    • Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.
    • Reference

    • Antiviral Res. 2006 Feb;69(2):70-6.
    • Author

    • Ho TY, Wu SL, Chen JC, Wei YC, Cheng SE, Chang YH, Liu HJ, Hsiang CY.